Share:
Research Letter

A Case of Xanthoma Disseminatum in a Progressive Form With Bladder Involvement Effectively Treated With 2-Chlorodeoxyadenosine

Author Affiliation(s)

Abstract

References

1. Altman J, Winkelmann R. Xanthoma disseminatum. Arch Dermatol. 1962;86(5):582-596. DOI:10.1001/archderm.1962.01590110018003 2. Caputo R, Veraldi S, Grimalt R, et al. The various clinical patterns of xanthoma disseminatum. Dermatology. 1995;190(1):19-24. DOI: 10.1159/000246628. PMID: 7894090. 3. Zelger B, Cerio R, Orchard G, Fritsch P, Wilson-Jones E. Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X. Arch Dermatol. 1992;128(9):1207-1212. PMID: 1519935. 4. Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non‐Langerhans cell histiocytoses. Pediatr Blood Cancer. 2005;45(3):256-264. DOI: 10.1002/pbc.20246. PMID: 15547923. 5. Khezri F, Gibson LE, Tefferi A. Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series. Arch Dermatol. 2011;147(4):459-464. DOI: 10.1001/archdermatol.2010.378. PMID: 21173305. 6. Adışen E, Aladağ P, Özlem E, Gürer M. Cladribine is a promising therapy for xanthoma disseminatum. Clin Exp Dermatol. 2017;42(6):717-719. DOI: 10.1111/ced.13116. PMID: 28544144.

Send mail to Author


Send Cancel